Cargando…

Perspectives and experiences with COVID-19 vaccines in people with MS

BACKGROUND: People with MS may have unique perspectives on COVID-19 vaccines due to their condition and/or medications. OBJECTIVE: Assess perspectives and experiences with COVID-19 vaccination, and quantify variables impacting COVID-19 vaccine willingness in people with MS. METHODS: A survey capture...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ciotti, John R., Perantie, Dana C., Moss, Brandon P., Fitzgerald, Kathryn C., Cohen, Jeffrey A., Mowry, Ellen M., Naismith, Robert T., Chahin, Salim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902317/ https://www.ncbi.nlm.nih.gov/pubmed/35273809 http://dx.doi.org/10.1177/20552173221085242

Ejemplares similares

Obesity's role in MS: An intervention target with possible interactions
por: Fitzgerald, Kathryn C., et al.
Publicado: (2020)

Diffusion basis spectrum imaging provides insights into MS pathology
por: Sun, Peng, et al.
Publicado: (2019)

Diffusion basis spectrum imaging for identifying pathologies in MS subtypes
por: Shirani, Afsaneh, et al.
Publicado: (2019)

Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy
por: Gadani, Sachin P., et al.
Publicado: (2021)

Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy
por: Gadani, Sachin P., et al.
Publicado: (2021)

Effects of MS disease-modifying therapies on responses to vaccinations: A review.
por: Ciotti, John Robert, et al.
Publicado: (2020)

Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health Solutions
por: Cohen, Jeffrey A, et al.
Publicado: (2022)

Exploring the impact of the COVID-19 pandemic on social isolation and mental health in people with MS
por: Ling, Shu, et al.
Publicado: (2022)

Associations of sNfL with clinico‐radiological measures in a large MS population
por: Sotirchos, Elias S., et al.
Publicado: (2022)

A Phase 1b, Open-Label Study to Evaluate the Safety and Tolerability of the Putative Remyelinating Agent, Liothyronine, in Individuals with MS
por: Newsome, Scott D., et al.
Publicado: (2023)

Environmental and genetic risk factors for MS: an integrated review
por: Waubant, Emmanuelle, et al.
Publicado: (2019)

Rapid transfer of knowledge for multiple sclerosis clinical care during COVID-19: ECHO MS
por: Alschuler, Kevin N., et al.
Publicado: (2020)

Multiple sclerosis diagnosis: Knowledge gaps and opportunities for educational intervention in neurologists in the United States
por: Solomon, Andrew J, et al.
Publicado: (2021)

Intermittent calorie restriction alters T cell subsets and metabolic markers in people with multiple sclerosis
por: Fitzgerald, Kathryn C., et al.
Publicado: (2022)

Telemedicine during the Coronavirus Disease (COVID-19) Pandemic: A Multiple Sclerosis (MS) Outpatients Service Perspective
por: Corea, Francesco, et al.
Publicado: (2021)

Association of Vitamin D Polygenic Risk Scores and Disease Outcome in People With Multiple Sclerosis
por: Vasileiou, Eleni S., et al.
Publicado: (2022)

Gene Therapy for ALS—A Perspective
por: Cappella, Marisa, et al.
Publicado: (2019)

iPSCs from people with MS can differentiate into oligodendrocytes in a homeostatic but not an inflammatory milieu
por: Morales Pantoja, Itzy E., et al.
Publicado: (2020)

Clinical features and outcomes of COVID-19 despite SARS-CoV-2 vaccination in people with multiple sclerosis
por: Rose, Deja R, et al.
Publicado: (2021)

Leveraging real-world data to investigate multiple sclerosis disease behavior, prognosis, and treatment
por: Cohen, Jeffrey A, et al.
Publicado: (2019)

Management strategies for lower urinary tract symptoms (LUTS) among people with multiple sclerosis (MS): a qualitative study of the perspectives of people with MS and healthcare professionals
por: Al Dandan, Hawra B., et al.
Publicado: (2019)

Central vein sign: A diagnostic biomarker in multiple sclerosis (CAVS-MS) study protocol for a prospective multicenter trial
por: Ontaneda, D., et al.
Publicado: (2021)

Using real-world accelerometry-derived diurnal patterns of physical activity to evaluate disability in multiple sclerosis
por: Keller, Jennifer L., et al.
Publicado: (2022)

Hippocampal Volumes in Youth With Type 1 Diabetes
por: Hershey, Tamara, et al.
Publicado: (2010)

Dimethyl fumarate treatment induces lipid metabolism alterations that are linked to immunological changes
por: Bhargava, Pavan, et al.
Publicado: (2018)

Proposal for Current Distribution Measurements on the Frascati sex-up experiment
por: Ciotti, M
Publicado: (2003)

The Neurophysiologist Perspective into MS Plasticity
por: Houdayer, Elise, et al.
Publicado: (2015)

Physical Disability, Anxiety and Depression in People with MS: An Internet-Based Survey via the UK MS Register
por: Jones, Kerina H., et al.
Publicado: (2014)

Provision of and trust in COVID‐19 vaccines information: Perspectives of people who have had COVID‐19
por: Schackmann, Laura, et al.
Publicado: (2023)

“Brain age” predicts disability accumulation in multiple sclerosis
por: Brier, Matthew R., et al.
Publicado: (2023)

COVID 19 vaccination and people with disability: Australian perspective
por: Shoib, Sheikh, et al.
Publicado: (2022)

Experiences and Perspectives of GC-MS Application for the Search of Low Molecular Weight Discriminants of Schizophrenia
por: Porozova, Natalia, et al.
Publicado: (2022)

Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS)
por: Mowry, Ellen M., et al.
Publicado: (2020)

Myelin oligodendrocyte glycoprotein-IgG associated disorders (MOGAD) following SARS-CoV-2 infection: A case series
por: Lambe, Jeffrey, et al.
Publicado: (2022)

High-dose vitamin D(3) supplementation in relapsing-remitting multiple sclerosis: a randomised clinical trial
por: Cassard, Sandra D., et al.
Publicado: (2023)

Autistic People’s Perinatal Experiences II: A Survey of Childbirth and Postnatal Experiences
por: Hampton, S., et al.
Publicado: (2022)

Diverse perspectives and lived experiences of educational work
por: Fitzgerald, Ange, et al.
Publicado: (2022)

Prospectively Determined Impact of Type 1 Diabetes on Brain Volume During Development
por: Perantie, Dana C., et al.
Publicado: (2011)

Willingness to receive a COVID-19 vaccine in people with multiple sclerosis – UK MS Register survey
por: Huang, Yun, et al.
Publicado: (2021)

The Impact of Patients’ Demographics, Insurance Payor and Comorbidities on Pneumococcal Vaccine Uptake in a Resident Community Internal Medicine Clinic
por: AlSalman, Ahmad, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kdi37g7b19s6i66avatkqr8ltu